The Molecular Biology of Myeloma
David S. Siegel, MD, PhD
Video Categories: Targeted Therapies
PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.
Dr Gerson discusses the process in which genetic changes cause tumors to grow.